SpringWorks Therapeutics, Inc. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
SpringWorks Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from 2018 to 2024.
  • SpringWorks Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $21.5M, a 78.2% decline year-over-year.
  • SpringWorks Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $64.5M, a 85.7% increase from 2023.
  • SpringWorks Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $34.8M.
  • SpringWorks Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$216M, a 358% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.